CG Invites Co., Ltd.
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
Other Names/Subsidiaries
- Bexpharm
- Bexpharm Korea
- CG Pharmaceuticals
- CrystalGenomics
- Hwail Pharmaceutical
- Palkion
Latest on CG Invites Co., Ltd.
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Biocytogen Licenses Antibodies For
Ildong Pharmaceutical Co., Ltd. has joined hands with Shionogi & Co. Ltd. to develop in South Korea the Japanese company's oral antiviral candidate for COVID-19, S-217622. Ildong has already receiv
Aptose Biosciences Inc. has reached an exclusive global license agreement worth up to $420m with Hanmi Pharmaceutical Co., Ltd. to develop and commercialize in all indications HM43239, the major So
South Korean companies are adopting a “select and focus” strategy to gain flexibility and speed in progressing R&D. Under these plans, pharma and biotech firms are spinning off promising pipelines or